• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄膜炎患者血清白细胞介素2受体水平

Serum interleukin 2-receptor levels in uveitis.

作者信息

Arocker-Mettinger E, Asenbauer T, Ulbrich S, Grabner G

机构信息

2nd Department of Ophthalmology, University of Vienna, Austria.

出版信息

Curr Eye Res. 1990;9 Suppl:25-9. doi: 10.3109/02713689008999415.

DOI:10.3109/02713689008999415
PMID:2384010
Abstract

This study reports on serum interleukin 2-receptor (IL-2R) levels in uveitis patients. IL-2R is the mediator protein of interleukin 2 (IL-2), a mitogenetic cytokine of primarily immune cell interaction. Stimulated T-cells readily express IL-2R on their cell surface and release a soluble form into serum. The measurement of IL-2R serum levels was performed using a monoclonal antibody based ELISA with age and sex matched healthy blood donors serving as the control group. The increase of IL-2R serum levels in patients affected by heterochromic cyclitis Fuchs (HCF) and a small group of children with chronic anterior uveitis affected by juvenile rheumatoid arthritis (JRA) was statistically highly significant, when compared to the control group (n = 84, alpha = 0.01). Serum levels of patients with intermediate uveitis (IU), patients with HLA-B27 positive acute anterior uveitis (AAU) and patients with HLA-B27 negative AAU did not differ significantly from the controls.

摘要

本研究报告了葡萄膜炎患者血清白细胞介素2受体(IL-2R)水平。IL-2R是白细胞介素2(IL-2)的介质蛋白,IL-2是主要参与免疫细胞相互作用的促有丝分裂细胞因子。受刺激的T细胞易于在其细胞表面表达IL-2R,并向血清中释放可溶性形式。使用基于单克隆抗体的酶联免疫吸附测定法(ELISA)测量IL-2R血清水平,以年龄和性别匹配的健康献血者作为对照组。与对照组(n = 84,α = 0.01)相比,富克斯异色性睫状体炎(HCF)患者以及一小部分受幼年类风湿性关节炎(JRA)影响的慢性前葡萄膜炎儿童患者的IL-2R血清水平升高具有高度统计学意义。中间葡萄膜炎(IU)患者、HLA-B27阳性急性前葡萄膜炎(AAU)患者和HLA-B27阴性AAU患者的血清水平与对照组无显著差异。

相似文献

1
Serum interleukin 2-receptor levels in uveitis.葡萄膜炎患者血清白细胞介素2受体水平
Curr Eye Res. 1990;9 Suppl:25-9. doi: 10.3109/02713689008999415.
2
Circulating ICAM-1 levels in serum of uveitis patients.葡萄膜炎患者血清中循环细胞间黏附分子-1水平。
Curr Eye Res. 1992;11 Suppl:161-6. doi: 10.3109/02713689208999527.
3
Elevated Interleukin 37 Expression Associated With Disease Activity in HLA-B27 Associated Anterior Uveitis and Idiopathic Anterior Uveitis.白细胞介素37表达升高与HLA - B27相关性前葡萄膜炎及特发性前葡萄膜炎的疾病活动相关。
Curr Mol Med. 2018 Mar 9;17(7):460-467. doi: 10.2174/1566524018666180207152941.
4
Prevalence and levels of serum antibodies to gram negative microorganisms in Turkish patients with HLA-B27 positive acute anterior uveitis and controls.土耳其 HLA - B27 阳性急性前葡萄膜炎患者及对照组中革兰氏阴性微生物血清抗体的患病率及水平
Ocul Immunol Inflamm. 2006 Oct;14(5):293-9. doi: 10.1080/09273940600977241.
5
[Serum soluble interleukin-2 receptor levels in uveitis].[葡萄膜炎患者血清可溶性白细胞介素-2受体水平]
Yan Ke Xue Bao. 1998 Jun;14(2):64-5.
6
Expression profile of IL-1 family cytokines in aqueous humor and sera of patients with HLA-B27 associated anterior uveitis and idiopathic anterior uveitis.HLA - B27相关性前葡萄膜炎和特发性前葡萄膜炎患者房水和血清中白细胞介素 - 1家族细胞因子的表达谱
Exp Eye Res. 2015 Sep;138:80-6. doi: 10.1016/j.exer.2015.06.018. Epub 2015 Jun 24.
7
Preliminary Report on Interleukin-22, GM-CSF, and IL-17F in the Pathogenesis of Acute Anterior Uveitis.白细胞介素-22、GM-CSF 和 IL-17F 在急性前葡萄膜炎发病机制中的初步报告。
Ocul Immunol Inflamm. 2021 Apr 3;29(3):558-565. doi: 10.1080/09273948.2019.1686156. Epub 2019 Nov 25.
8
Cytokine Expression Profile in Aqueous Humor and Sera of Patients with Acute Anterior Uveitis.急性前葡萄膜炎患者房水和血清中的细胞因子表达谱
Curr Mol Med. 2015;15(6):543-9. doi: 10.2174/1566524015666150731100012.
9
Soluble ICAM-1 serum levels in patients with intermediate uveitis.中间葡萄膜炎患者血清可溶性细胞间黏附分子-1水平
Br J Ophthalmol. 1999 Jul;83(7):847-51. doi: 10.1136/bjo.83.7.847.
10
The Rate of Helicobacter pylori Seropositivity in a Group of Korean Patients with HLA-B27-Associated Acute Anterior Uveitis.一组韩国 HLA - B27 相关急性前葡萄膜炎患者的幽门螺杆菌血清阳性率
PLoS One. 2015 Apr 20;10(4):e0123924. doi: 10.1371/journal.pone.0123924. eCollection 2015.

引用本文的文献

1
Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative.基于共识的幼年特发性关节炎相关葡萄膜炎管理推荐:SHARE 倡议。
Ann Rheum Dis. 2018 Aug;77(8):1107-1117. doi: 10.1136/annrheumdis-2018-213131. Epub 2018 Mar 28.
2
Elevated inflammatory cytokines in aqueous cytokine profile in HIV-1 infected patients with cataracts in Uganda.乌干达感染HIV-1的白内障患者房水细胞因子谱中炎性细胞因子升高。
BMC Ophthalmol. 2018 Jan 19;18(1):12. doi: 10.1186/s12886-018-0680-y.
3
Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis.
白细胞介素-2受体和血管紧张素转换酶作为眼部结节病的标志物
PLoS One. 2016 Jan 22;11(1):e0147258. doi: 10.1371/journal.pone.0147258. eCollection 2016.
4
Genetic of uveitis.葡萄膜炎的遗传学
Int Ophthalmol. 2016 Jun;36(3):419-33. doi: 10.1007/s10792-015-0136-9. Epub 2015 Oct 9.
5
Influence of molecular genetics in Vogt-Koyanagi-Harada disease.分子遗传学在Vogt-小柳-原田病中的影响。
J Ophthalmic Inflamm Infect. 2014 Jul 22;4:20. doi: 10.1186/s12348-014-0020-1. eCollection 2014.
6
Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis.重度幼年特发性关节炎相关葡萄膜炎的风险标志物及预后研究进展
Int J Clin Rheumtol. 2013 Feb 1;8(1). doi: 10.2217/ijr.12.83.
7
Complement factor H and interleukin gene polymorphisms in patients with non-infectious intermediate and posterior uveitis.非感染性中间葡萄膜炎和后葡萄膜炎患者的补体因子H和白细胞介素基因多态性
Mol Vis. 2012;18:1865-72. Epub 2012 Jul 11.
8
CFH 184G as a genetic risk marker for anterior uveitis in Chinese females.CFH 184G作为中国女性前葡萄膜炎的遗传风险标志物。
Mol Vis. 2011;17:2655-64. Epub 2011 Oct 13.
9
Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation.当前非感染性眼内炎症发病机制和治疗的新概念和未来方向。
Eye (Lond). 2012 Jan;26(1):17-28. doi: 10.1038/eye.2011.255. Epub 2011 Sep 30.
10
Soluble ICAM-1 serum levels in patients with intermediate uveitis.中间葡萄膜炎患者血清可溶性细胞间黏附分子-1水平
Br J Ophthalmol. 1999 Jul;83(7):847-51. doi: 10.1136/bjo.83.7.847.